Abstract
Objectives The aim of this paper is to perform a Statewise Analysis of the Second Covid Wave experienced by India using the Gompertz Curves and to assess the role played by vaccinations in reshaping the trajectory of Covid Infections for India. A total of 21 prominent states are chosen for the analysis encompassing 97% of the Indian population. Since the vaccination program in India was rolled out after the First wave of infections had almost subsided, the current analysis is only relevant for the Second Wave.
Methods We will try to explore how the different properties of the Gompertz Curves can be used as a convenient tool to study the COVID-19 outbreak in India. The impact of vaccinations has also been studied at the state level to assess the extent to which the roll out of vaccination program has augmented the covid scenario of India. Vaccinations have been incorporated in the analysis by taking the daily cumulative number of individuals having the first and second shots of vaccine in each state as the explanatory variables.
Results The preliminary question that the paper tries to investigate is whether the vaccines capable of checking infection growth. Out of the chosen 21 states, 16 states show positive outcomes with some observable ambiguity for the states of Telangana, West Bengal, Tamil Nadu, Rajasthan and Kerala.
Conclusions Our analysis found that most of the states (16 out of 21 states) has positive impact of vaccination in reducing the Covid-19 cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Palash Ghosh would like to acknowledge support by the ICMR Centre for Excellence, Grant no. 5/3/8/20/2019-ITR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data used are available online.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The updated data on infections can be downloaded from \url{www.kaggle.com/datasets/vinitshah0110/covid19-india?resource=download }, and the statewise data on vaccinations is available at \url{www.kaggle.com/datasets/harveenchadha/india-covid19-vaccination-data?select=vaccination.csv}
https://www.kaggle.com/datasets/vinitshah0110/covid19-india?resource=download
